• Filing Date: 2013-09-27
  • Form Type: 10-K
  • Description: Annual report
v2.4.0.8
4. AGREEMENT WITH ASTRAZENECA (Details Narrative) (USD $)
12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2011
Agreement With Astrazeneca Details Narrative      
Revenue recognized under clinical trail sponsored research agreements $ 10,361 $ 73,736 $ 497,540